MSD en las noticias
Ciencia de vanguardia para la salud
Tamtam encontró 20 artículos recientes sobre MSD.
- MSD’s Phase IIb study of tulisokibart achieves primary endpoint
- MSD’s Phase IIb study of tulisokibart achieves primary endpoint
- MSD announces phase 2 results for tulisokibart in moderate to severe hidradenitis suppurativa
- MSD Korea launches subcutaneous Keytruda, cutting injection time to 1–2 minutes
- PAHO and MSD for Mothers sign agreement to reduce preventable maternal deaths in Guatemala and the Dominican Republic
- MSD bets $2.13bn on SciBrunch’s KRAS (ON) inhibitor
- Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial
- MSD backs Ingenia as sole phase 3 TIE2 eye drug advances in Korea and US - CHOSUNBIZ
- MSD takes a $400m bite of SciBrunch's KRAS drug
- MSD Appoints Vidhya Sundaram As AVP, Global Technology Centers
- MSD, Daiichi pull filing for lung cancer candidate I-DXd
- MSD appoints Vidhya Sundaram as Associate Vice President, Global Technology Centers and Hyderabad Tech Center Lead
- Daiichi Sankyo, MSD withdraw cancer drug application
- MSD’s eye drug meets primary endpoint in trial
- Bio Farma and MSD Expand Strategic Partnership to Strengthen Local Vaccine Manufacturing Capabilities
- Wnt drug gives MSD first eye disease win after EyeBio deal
- MSD’s DME drug could challenge anti-VEGF reign, late-stage study suggests
- MSD’s DME drug could challenge anti-VEGF reign, late-stage study suggests
- MSD receives first shipment of Naltrexone for the treatment of alcohol addiction
- MSD reaffirms commitment to advancing women’s cancer care
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como MSD?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares